Yes, this product is soluble in DMSO. Further details on the preparation of a 5 micromolar working concentration from a 5 Molar freshly prepared stock solution in DMSO can be found in the publication "Cancer Res., 61, 6331-6334 (2001)" by A. Chetcuti et al.
A2385
5-azacitidina
≥98% (HPLC), powder, DNA methyltransferase inhibitor
Sinonimo/i:
4-amino-1-(β-D-ribofuranosil)-1,3,5-triazin-2(1H)-one, Ladakamicina
Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
| Taglio della confezione | SKU | Disponibilità | Prezzo |
|---|---|---|---|
| 250 mg | Per conoscere la disponibilità, visualizza il carrello | CHF 116.00 | |
| 100 mg | Per conoscere la disponibilità, visualizza il carrello | CHF 132.00 | |
| 1 g | Per conoscere la disponibilità, visualizza il carrello | CHF 418.00 |
Informazioni su questo articolo
Formula empirica (notazione di Hill):
C8H12N4O5
Numero CAS:
Peso molecolare:
244.20
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
206-280-2
MDL number:
Beilstein/REAXYS Number:
620461
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartiNome del prodotto
5-azacitidina, ≥98% (HPLC)
Quality Level
assay
≥98% (HPLC)
form
powder
mp
226-232 °C (dec.) (lit.)
antibiotic activity spectrum
viruses
mode of action
DNA synthesis | interferes
originator
Celgene
storage temp.
−20°C
SMILES string
NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
InChI
1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
InChI key
NMUSYJAQQFHJEW-KVTDHHQDSA-N
Gene Information
human ... DNMT1(1786), DNMT3A(1788), DNMT3B(1789)
General description
Chemical structure: nucleoside
5-Azacytidine is a chemical analog of cytidine. It functions as a hypomethylating agent. 5-Azacytidine is used to treat myelodysplastic syndrome (MDS).
Application
5-Azacytidine has been used:
- for cell induction
- to study its effects on bovine fetal mesenchymal stem cells (bfMSC)
- to study its effects on human bone marrow stromal cells (hBMSCs)
- to study its effects on and DNA methyltransferase 1 (DNMT1) and Ras protein activator like 1 (RASAL1) expression
- to interfere with DNA methylation and histone acetylation
- to determine its effects on the conversion of control fibroblasts
- for optical coherence tomography (OCT) and fluorescein angiography (FA)
- for the reactivation of Sal-like protein (SALL)3 expression
Biochem/physiol Actions
Potente inibitore della proliferazione e agente citotossico; inibisce la DNA metiltransferasi, un importante meccanismo di regolazione dell′espressione genica, dell′attivazione e del silenziamento genico.
Potente inibitore della proliferazione e agente citotossico; inibisce la DNA metiltransferasi.
Causes DNA demethylation or hemi-demethylation, creating openings that allow transcription factors to bind to DNA and reactivate tumor suppressor genes.
5-Azacytidine (Aza-CR) acts as a potential chemotherapeutic regimen for acute myelogenous leukemia.[1] This drug has an ability to selectively increase γ-globin synthesis. Therefore, 5-azacytidine is used in treating severe β-thalassemia. Aza-CR acts as a potential bacteriostatic, antitumor and mutagenic agent. In addition, it also exhibits various biological activity such as, immunosuppressive, antimitotic, radioprotective and virostatic effects.
Features and Benefits
This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound was developed by Celgene. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
1 of 1
Questo articolo | |||
|---|---|---|---|
| assay ≥98% (HPLC) | assay - | assay - | assay - |
| form powder | form powder | form lyophilized powder | form - |
| Quality Level 200 | Quality Level 300 | Quality Level 200 | Quality Level - |
| storage temp. −20°C | storage temp. 2-8°C | storage temp. −20°C | storage temp. - |
| originator Celgene | originator - | originator - | originator - |
| Gene Information human ... DNMT1(1786), DNMT3A(1788), DNMT3B(1789) | Gene Information human ... DNMT1(1786), DNMT3A(1788) | Gene Information human ... DNMT1(1786), DNMT3A(1788) | Gene Information human ... DNMT1(1786), DNMT3A(1788) |
Still not finding the right product?
Explore all of our products under 5-azacitidina
signalword
Danger
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 1 - Carc. 1A - Muta. 2 - Repr. 1B - STOT RE 1
Classe di stoccaggio
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
ppe
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Articoli
We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.
Cancer research has revealed that the classical model of carcinogenesis, a three step process consisting of initiation, promotion, and progression, is not complete.
Epigenetic modifications in hyperhomocysteinemia: potential role in diabetic retinopathy and age-related macular degeneration
Elmasry K, et al.
Testing, 9(16), 12562-12562 (2018)
Myogenic differentiation potential of mesenchymal stem cells derived from fetal bovine bone marrow
Okamura LH, et al.
Animal Biotechnology, 29(1), 1-11 (2018)
Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment
Constantinides PG, et al.
Nature, 267(5609), 364-364 (1977)
Numero articolo commerciale globale
| SKU | GTIN |
|---|---|
| A2385-250MG | 04061833350096 |
| A2385-1G | 04061833350089 |
| A2385-100MG | 04061833350072 |
-
I have purchased azacytidine 100 mg and was wondering if it can be dissolved in something else then in tissue culture medium and acetic acid:water as it is specified in the product sheet. I found that it can be dissolved in DMSO at 30 mg/ml.
1 answer-
Helpful?
-
-
Is Product A2385 soluble in DMSO?
1 answer-
Yes it is soluble in DMSO. In the publication "Cancer Res., 61, 6331-6334 (2001)" by A. Chetcuti et al., there are further details on the preparation of a 5 micromolar working concentration from a 5 Molar freshly prepared stock solution in DMSO.
Helpful?
-
-
I just need to perform a purity assay on Product No. A2385 (5-Azacytidine). What would you recommend?
1 answer-
We assay the purity of this product by HPLC. If you would like to obtain a copy of our HPLC parameters/method, please contact your local Sigma-Aldrich Technical Service group.
Helpful?
-
-
What is the Department of Transportation shipping information for this product?
1 answer-
Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.
Helpful?
-
-
I need to perform an identity test on Product No. A2385 (5-Azacytidine). What would you recommend?
1 answer-
This means that each lot is tested according to the list of tests (left hand column), and must meet or exceed the specifications (right hand column). HPLC. The elemental analyses for carbon and nitrogen content are identity tests (albeit not absolutely conclusive identity tests). I would say that the HPLC, using a previous lot of A2385 as a control sample, provides the best evidence for identity and purity.
Helpful?
-
-
What is Product No. A2385 (5-Azacytidine) used for?
1 answer-
This nucleoside analog has been used variously as an antitumor agent and as a mutagenic agent.
Helpful?
-
-
What is the solution stability of Product No. A2385? That is, how should I store solutions of 5-Azacytidine?
1 answer-
We generally don't recommend storing solutions, since it has such poor solution stability. In Cancer Res., 61, 6331-6334 (2001), A. Chetcuti et al. describe preparing a 5 micromolar working concentration from a 5 Molar freshly prepared stock solution in DMSO.
Helpful?
-